GO:1901981 phosphatidylinositol phosphate binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901981 phosphatidylinositol phosphate binding describes the molecular function of selectively binding phosphatidylinositol phosphate (PIP) lipids, including PI3P, PI4P, and PI(4,5)P2.
• PIP-binding modules such as FYVE, PX, PH, and PROPPIN domains decode membrane lipid identity and recruit proteins to specific organelles.
• PI3P-binding proteins control autophagy, endosomal sorting, and iron transport, linking lipid binding to cellular homeostasis.
• PI4P on the dispersed trans-Golgi network acts as a licensing signal for NLRP3 inflammasome activation through PIP-binding events.
• PIP binding is highly specific: neuronal calcium sensor-1 (NCS-1) interacts preferentially with PI3P, illustrating lipid-headgroup discrimination.
• Dysregulated PIP binding contributes to neurodegeneration, cancer, and inflammatory diseases, making it a target for CRISPR-based functional studies.
Description
Phosphatidylinositol phosphate binding (GO:1901981) is a molecular function that enables a protein to selectively recognize and bind phosphatidylinositol phosphate (PIP) lipids within cellular membranes. PIPs are phosphorylated derivatives of phosphatidylinositol that serve as membrane landmarks, and their binding by effector proteins is a fundamental mechanism for spatial and temporal organization of eukaryotic cells. The QuickGO definition states that this term encompasses binding to phosphatidylinositol phosphate, a class of lipids that includes PI3P, PI4P, PI(4,5)P2, and other phosphorylated species. Researchers study this function because it underlies processes as diverse as autophagy, inflammasome activation, iron homeostasis, and neuronal signaling. The functional importance of phosphatidylinositol phosphate binding is rooted in the ability of proteins to decode lipid codes. For example, the FYVE finger domain is a dedicated PI3P-binding module that targets proteins to endosomes, while PX and PH domains recognize other PIP species with varying specificity. These interactions are not merely passive anchors; they can induce conformational changes that activate signaling cascades, as seen when PI4P on the dispersed trans-Golgi network triggers NLRP3 inflammasome assembly. Similarly, the PI3P-binding protein SNX4 controls ATG9A recycling to sustain autophagy, demonstrating how lipid binding directly impacts membrane trafficking. Given the broad physiological roles of PIP-binding proteins, understanding their mechanisms has direct biomedical relevance. Mutations or dysregulation in PIP-binding proteins are implicated in cancer, neurodegeneration, and immune disorders. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:1901981, covering its definition, molecular mechanism, key genes, disease connections, and experimental strategies including CRISPR-based models.
phosphatidylinositol phosphate binding At A Glance
| GO ID | GO:1901981 |
|---|---|
| GO term | phosphatidylinositol phosphate binding |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Binding to phosphatidylinositol phosphate. |
| Major function | Selective recognition of PIP lipids to recruit proteins to membranes and regulate signaling, trafficking, and autophagy. |
| Representative domains | FYVE, PX, PH, PROPPIN, and other PIP-binding modules. |
| Key lipid ligands | PI3P, PI4P, PI(4,5)P2, and other phosphorylated phosphatidylinositols. |
| Associated processes | Autophagy, endosomal sorting, inflammasome activation, iron transport, neuronal signaling. |
What Is GO:1901981?
Phosphatidylinositol phosphate binding (GO:1901981) is the molecular function of selectively and non-covalently interacting with a phosphatidylinositol phosphate molecule. Phosphatidylinositol phosphates are glycerophospholipids in which the inositol ring is phosphorylated at one or more positions, generating species such as PI3P, PI4P, and PI(4,5)P2. Proteins that perform this function typically contain specialized lipid-binding domains (e.g., FYVE, PX, PH, PROPPIN) that insert into or dock onto membrane bilayers to read the PIP code. This binding event can serve to recruit the protein to a specific membrane compartment, to alter the protein's enzymatic activity, or to nucleate larger signaling complexes. The term is a child of phosphatidylinositol binding and is distinct from binding to other phospholipids such as phosphatidylserine or phosphatidylcholine.
Why Is phosphatidylinositol phosphate binding Important in Cell Biology?
Phosphatidylinositol phosphate binding is a central mechanism by which cells interpret lipid signals to control membrane identity and signaling output. Because PIPs are unevenly distributed across organelles, PIP-binding proteins act as molecular GPS devices that direct cellular machinery to the right place at the right time. This function is essential for autophagy, where PI3P-binding proteins such as SNX4 coordinate ATG9A recycling, and for innate immunity, where PI4P binding on the Golgi triggers NLRP3 inflammasome activation. Disruption of PIP binding is linked to neurodegeneration, cancer, and inflammatory diseases, underscoring its biomedical importance.
• PIP-binding domains such as FYVE and PX are evolutionarily conserved modules that target proteins to endosomes and autophagosomes.
• PI3P binding by SNX4 is required for ATG9A recycling and autophagosome formation, linking lipid recognition to autophagy.
• PI4P on the dispersed trans-Golgi network serves as a licensing signal for NLRP3 inflammasome activation via PIP-binding events.
• The PI3P-binding protein CgPil1 regulates iron transport, showing a role in metal homeostasis.
• Neuronal calcium sensor-1 (NCS-1) binds PI3P with high specificity, implicating PIP binding in neuronal signaling.
• PIP5K1A membrane recognition depends on phosphatidylinositol phosphate binding, affecting PIP2 synthesis.
• STING activation by a chemical agonist and Golgi-resident PI4P involves transmembrane helix rearrangement, highlighting PIP binding in immune signaling.
• Dysregulated PIP binding is associated with cancer, neurodegeneration, and inflammatory disorders.
• CRISPR screens targeting PIP-binding proteins can reveal new therapeutic targets.
• Understanding PIP binding informs drug design for autophagy modulators and inflammasome inhibitors.
What Happens During phosphatidylinositol phosphate binding?
Membrane recruitment and lipid recognition
In simple terms: Proteins with PIP-binding domains find and attach to specific membrane lipids.
The first step in phosphatidylinositol phosphate binding is the recognition of a specific PIP lipid within a membrane bilayer. Proteins containing FYVE, PX, or PH domains diffuse in the cytosol until their lipid-binding pocket encounters a compatible PIP headgroup, such as PI3P on endosomes or PI4P on the Golgi. This interaction is electrostatic and stereospecific, often involving conserved basic residues that coordinate the phosphate groups of the inositol ring. For example, the FYVE finger of early endosomal antigen 1 (EEA1) binds PI3P with high affinity, anchoring the protein to endosomal membranes. Similarly, the PI3P-binding protein CgPil1 is recruited to membranes to regulate iron transport.
Conformational change and complex assembly
In simple terms: Binding to the lipid can flip a protein into an active shape and gather other proteins.
Upon PIP binding, many proteins undergo conformational changes that expose interaction surfaces or activate enzymatic domains. This can nucleate the assembly of larger signaling complexes. A well-characterized example is the NLRP3 inflammasome: PI4P on the dispersed trans-Golgi network binds to NLRP3, inducing a conformational rearrangement that promotes inflammasome assembly and downstream gasdermin D-mediated pyroptosis. In another case, the phosphatidylinositol phosphate kinase PIP5K1A binds to membranes through PIP recognition, which positions its catalytic domain for subsequent PIP2 synthesis. These events demonstrate how lipid binding is not merely a tethering step but a trigger for functional outputs.
Downstream signaling and membrane trafficking
In simple terms: Once bound, the protein directs cellular traffic or signals to other processes.
After PIP binding, proteins often execute downstream functions such as vesicle transport, autophagy, or immune signaling. SNX4, a PI3P-binding protein, controls the recycling of ATG9A, a transmembrane protein essential for autophagosome biogenesis. Loss of SNX4 function impairs autophagy, highlighting the importance of PIP binding in membrane remodeling. In neurons, NCS-1 binds PI3P to modulate calcium signaling and neurotransmitter release, linking PIP binding to synaptic function. Additionally, STING activation by a chemical agonist and Golgi-resident PI4P involves transmembrane helix rearrangement, showing that PIP binding can directly regulate immune adaptor proteins.
Termination and regulation of binding
In simple terms: The interaction is reversible and can be turned off by lipid modification or protein changes.
Phosphatidylinositol phosphate binding is dynamically regulated. Lipid phosphatases can dephosphorylate PIPs, removing the binding site and releasing the protein. For instance, the conversion of PI(3,4,5)P3 to PI(4,5)P2 by PTEN-like phosphatases alters membrane recruitment of PH-domain proteins. Protein phosphorylation or competitive binding by other factors can also modulate affinity. In the context of autophagy, the PI3P-binding protein SNX4 cycles on and off membranes in coordination with ATG9A trafficking. These regulatory layers ensure that PIP binding is spatially and temporally controlled, preventing inappropriate signaling.
Key Genes Involved in GO:1901981 phosphatidylinositol phosphate binding
The following genes encode proteins that directly bind phosphatidylinositol phosphates or are core components of PIP-binding complexes, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SNX4 | PI3P-binding sorting nexin that controls ATG9A recycling and autophagy | Autophagy regulation; knockout models show impaired autophagosome formation |
| NLRP3 | Binds PI4P on dispersed trans-Golgi network to trigger inflammasome activation | Inflammatory disease models; point mutations can alter lipid binding |
| PIP5K1A | Phosphatidylinositol phosphate kinase that binds PIPs for membrane recognition | PIP2 synthesis; structural studies of membrane interaction |
| NCS-1 | Neuronal calcium sensor that specifically binds PI3P | Neurodegeneration and synaptic signaling; KO mice available |
| CgPil1 | PI3P-binding protein regulating iron transport | Iron homeostasis; fungal models for transport studies |
| STING | Golgi-resident PI4P and chemical agonist activate STING via transmembrane helix rearrangement | Innate immunity; knock-in models for agonist response |
| EEA1 | FYVE finger protein that binds PI3P on endosomes | Endosomal trafficking; domain mapping studies |
| ATG9A | Transmembrane protein recycled by SNX4 in a PI3P-dependent manner | Autophagy initiation; trafficking assays |
| Gasdermin D | Executes pyroptosis downstream of NLRP3 inflammasome | Inflammation; cleavage assays |
| VPS34 | PI3K that generates PI3P for recruitment of FYVE and PX proteins | Autophagy and endocytosis; inhibitor studies |
| Hrs | FYVE-domain protein binding PI3P in endosomal sorting | Endosomal sorting; knockdown phenotypes |
| SAR1 | GTPase involved in COPII vesicle formation; may interact with PIP-binding proteins | ER-Golgi transport; live imaging |
| PTEN | Lipid phosphatase that converts PIP3 to PIP2, indirectly affecting PIP binding | Cancer; loss-of-function mutations |
| OCRL | Inositol polyphosphate 5-phosphatase that regulates PIP levels | Lowe syndrome; enzymatic assays |
| INPP4A | Phosphatase that dephosphorylates PI(3,4)P2, influencing PIP-binding protein recruitment | Neurological disorders; KO models |
| PIK3C3 | Vacuolar protein sorting 34, generates PI3P for autophagic recruitment | Autophagy; kinase-dead mutants |
| WIPI2 | PROPPIN domain protein that binds PI3P to promote autophagy | Autophagy; KO impairs LC3 lipidation |
| DFCP1 | FYVE-domain protein that binds PI3P at omegasomes | Autophagy imaging; fluorescent tagging |
How Is phosphatidylinositol phosphate binding Regulated?
Phosphatidylinositol phosphate binding is regulated at multiple levels. The availability of PIP lipids is controlled by lipid kinases and phosphatases: VPS34 generates PI3P, while PTEN and OCRL remove phosphates, thereby creating or eliminating binding sites. Compartmentalization further restricts binding; for example, PI4P is enriched on the Golgi and is required for NLRP3 inflammasome activation, whereas PI3P is concentrated on endosomes and autophagosomes. Protein-level regulation includes phosphorylation, which can alter the affinity of PIP-binding domains, and competitive interactions with other membrane components. In autophagy, the PI3P-binding protein SNX4 cycles in coordination with ATG9A trafficking, and its function is modulated by upstream signals such as mTORC1. Additionally, the lipid environment itself (e.g., membrane curvature and cholesterol content) influences binding efficiency, as shown for PIP5K1A. Together, these layers ensure that PIP binding is dynamic and context-dependent.
phosphatidylinositol phosphate binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SNX4 | Autophagy impairment in neurodegeneration | SNX4 knockout cell lines; LC3 flux assays |
| NLRP3 | Inflammasome-driven inflammatory diseases | NLRP3 point mutations affecting PI4P binding; IL-1beta ELISA |
| NCS-1 | Neurodegeneration and synaptic dysfunction | NCS-1 knockout neurons; calcium imaging |
| STING | Innate immune disorders and interferonopathies | STING knock-in with tagged PI4P-binding domain; reporter assays |
| CgPil1 | Iron transport disorders | CgPil1 deletion in fungal models; iron uptake assays |
Phosphatidylinositol phosphate binding in cancer
Alterations in PIP-binding proteins can drive tumorigenesis through dysregulated signaling and membrane trafficking. PTEN, a lipid phosphatase that controls PIP levels, is one of the most frequently mutated tumor suppressors; its loss increases PIP3 and alters the recruitment of PIP-binding effectors such as AKT. Similarly, OCRL mutations affect PIP homeostasis and are linked to Lowe syndrome, which includes cancer predisposition in some cases. Targeting PIP-binding domains with small molecules is an emerging therapeutic strategy, and CRISPR screens can identify which PIP-binding proteins are essential in specific cancer contexts.
Neurodegeneration and PIP binding
Neurons are highly dependent on precise membrane trafficking, and PIP-binding proteins are critical for synaptic function and survival. NCS-1 binds PI3P with high specificity and regulates calcium signaling; its dysfunction has been implicated in neurodegenerative and psychiatric disorders. Autophagy impairment, often caused by defective PI3P binding by proteins such as SNX4, contributes to the accumulation of toxic protein aggregates in diseases like Alzheimer's and Parkinson's. Modulating PIP binding could therefore be neuroprotective, and CRISPR models of PIP-binding proteins are valuable for dissecting these pathways.
Inflammatory and immune disorders
PI4P binding on the dispersed trans-Golgi network is a key step in NLRP3 inflammasome activation, which drives interleukin-1beta release and pyroptosis. Dysregulated inflammasome activity is implicated in gout, atherosclerosis, and autoinflammatory syndromes. STING, an innate immune adaptor, is also activated by Golgi-resident PI4P and a chemical agonist through transmembrane helix rearrangement, linking PIP binding to antiviral responses. Thus, PIP-binding proteins are attractive targets for anti-inflammatory drugs, and CRISPR knockout of NLRP3 or STING can validate their roles in disease models.
Iron transport and metabolic disorders
The PI3P-binding protein CgPil1 regulates iron transport, connecting PIP binding to metal homeostasis. Iron overload and deficiency disorders may involve altered trafficking of iron transporters, and PIP-binding proteins could influence these processes. Studying CgPil1 and its mammalian counterparts using CRISPR knockouts can reveal conserved mechanisms of iron regulation.
From phosphatidylinositol phosphate binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SNX4 impair autophagy via PI3P binding? | SNX4 knockout HeLa or HEK293 cells; western blot for LC3-II |
| How does PI4P binding to NLRP3 trigger inflammasome assembly? | NLRP3 point mutations in PI4P-binding pocket; knock-in macrophages |
| What is the role of NCS-1 PI3P binding in neurons? | NCS-1 knockout primary neurons; live-cell imaging |
| Can STING activation be modulated by Golgi PI4P? | STING knock-in with tagged Golgi-targeting sequence; IFN reporter |
| Does CgPil1 PI3P binding regulate iron transport? | CgPil1 overexpression and knockout in C. glabrata; iron sensitivity assays |
| Which PIP-binding proteins are essential for cancer cell growth? | CRISPR library screening in cancer cell lines; dropout analysis |
How to Study the phosphatidylinositol phosphate binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipid overlay assay | Direct binding of proteins to immobilized PIPs | Validate FYVE domain specificity for PI3P |
| Surface plasmon resonance | Real-time binding kinetics and affinity | Quantify PIP binding of purified proteins |
| Fluorescence microscopy | Subcellular localization of PIP biosensors | Visualize PI4P on Golgi during inflammasome activation |
| Co-immunoprecipitation | Protein-protein interactions in PIP-dependent complexes | Identify NLRP3 interactors upon PI4P binding |
| CRISPR knockout screening | Gene essentiality and pathway discovery | Find regulators of autophagy via SNX4 |
| Proximity labeling (BioID) | Interactome mapping in living cells | Map PIP-binding protein networks |
| Phospholipid mass spectrometry | Lipidomic quantification of PIP species | Measure changes in PI3P/PI4P levels |
| Live-cell imaging with TIRF | Single-molecule dynamics of membrane binding | Study PIP5K1A membrane recruitment |
Lipid overlay and binding assays
Lipid overlay assays using membrane-immobilized PIPs are a standard method to test direct binding of recombinant proteins. For example, FYVE finger domains can be probed with PI3P-spotted membranes to confirm specificity. Surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) provide quantitative affinity data. These methods are often used to validate hits from CRISPR screens or to characterize disease-associated mutations in PIP-binding domains.
Fluorescence microscopy and live-cell imaging
Fluorescently tagged PIP-binding domains (e.g., GFP-FYVE for PI3P, GFP-PH for PI(4,5)P2) are used as biosensors to visualize lipid distribution in live cells. This approach has revealed the enrichment of PI4P on the dispersed trans-Golgi network during NLRP3 activation. Co-localization with organelle markers and time-lapse imaging can track dynamic recruitment of proteins like SNX4 to autophagosomes. Advanced techniques such as total internal reflection fluorescence (TIRF) microscopy enable single-molecule analysis of binding events.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry (AP-MS) can identify proteins that bind specific PIPs. For example, pull-downs with PI3P-conjugated beads from cell lysates have uncovered novel PIP-binding proteins. Proximity labeling (BioID) using a PIP-binding domain fused to a promiscuous biotin ligase can map the interactome in living cells. These methods complement CRISPR screens by providing a systems-level view of PIP-binding networks.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens are powerful for identifying genes required for PIP-dependent processes. For instance, a screen for autophagy regulators identified SNX4 as essential for ATG9A recycling. Similarly, screens can uncover synthetic lethal interactions with PIP-binding proteins in cancer. Computational analysis of screen data, including pathway enrichment, helps prioritize candidates for follow-up.
How CRISPR Can Be Used to Study GO:1901981 phosphatidylinositol phosphate binding
Knockout
CRISPR knockout of genes encoding PIP-binding proteins is a direct way to assess loss-of-function phenotypes. For example, SNX4 knockout cells exhibit defective ATG9A recycling and impaired autophagy, which can be rescued by wild-type SNX4 but not by a PI3P-binding-deficient mutant. Similarly, NLRP3 knockout macrophages fail to activate the inflammasome in response to PI4P-dependent stimuli. Knockout models are essential for validating the causal role of PIP binding in cellular processes and for identifying downstream effectors.
Point Mutation
Point mutations that abolish PIP binding without affecting protein stability or folding are powerful tools to dissect the specific contribution of lipid binding. For instance, mutating conserved basic residues in the FYVE finger of EEA1 prevents PI3P binding and mislocalizes the protein. In NLRP3, mutations in the PI4P-binding pocket can block inflammasome assembly while preserving other functions. CRISPR-mediated knock-in of such point mutations allows study in the native genomic context, avoiding artifacts from overexpression.
Knock-in
Knock-in of tagged or reporter versions of PIP-binding proteins enables real-time tracking and biochemical isolation. For example, knocking in a GFP tag on SNX4 allows visualization of its trafficking to autophagosomes. Similarly, a knock-in of STING with a Golgi-targeting sequence can be used to study PI4P-dependent activation. Knock-in models are also useful for introducing disease-associated mutations found in patients, such as those in OCRL or NCS-1.
Overexpression
Overexpression of wild-type or mutant PIP-binding proteins can reveal gain-of-function phenotypes and dominant-negative effects. For example, overexpressing a PI3P-binding domain alone can sequester lipids and disrupt autophagy. Overexpression of constitutively active NLRP3 mutants can drive spontaneous inflammasome activation. However, overexpression must be carefully controlled because it can saturate binding sites and produce artifacts; CRISPR-mediated knock-in at safe-harbor loci offers a more physiological alternative.
How EDITGENE Supports phosphatidylinositol phosphate binding Research
Researchers studying phosphatidylinositol phosphate binding-related genes often need to determine whether a candidate gene is causally involved in a specific cellular process or disease. Establishing causality requires precise genetic manipulation, and CRISPR-based models provide the gold standard for such studies. Whether the goal is to eliminate protein function, introduce disease-relevant point mutations, tag endogenous proteins for imaging, or overexpress a gene of interest, the right model system is critical. EDITGENE offers a comprehensive suite of CRISPR services tailored to PIP-binding protein research, enabling reproducible and publication-ready results.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylinositol phosphate binding research.
Frequently Asked Questions About phosphatidylinositol phosphate binding
What is phosphatidylinositol phosphate binding?
Phosphatidylinositol phosphate binding (GO:1901981) is the molecular function of selectively binding phosphatidylinositol phosphate lipids, such as PI3P, PI4P, and PI(4,5)P2, typically through specialized domains like FYVE, PX, or PH.
What genes are involved in phosphatidylinositol phosphate binding?
Key genes include SNX4, NLRP3, PIP5K1A, NCS-1, CgPil1, STING, EEA1, and ATG9A, among others.
How does PI3P binding regulate autophagy?
PI3P-binding proteins such as SNX4 control the recycling of ATG9A, a transmembrane protein essential for autophagosome formation; loss of SNX4 impairs autophagy.
What is the role of PI4P in inflammasome activation?
PI4P on the dispersed trans-Golgi network binds NLRP3, inducing conformational changes that trigger inflammasome assembly and pyroptosis.
Which domains bind phosphatidylinositol phosphates?
Common PIP-binding domains include FYVE, PX, PH, and PROPPIN, each with preferences for specific PIP species.
How can I study phosphatidylinositol phosphate binding in the lab?
Methods include lipid overlay assays, surface plasmon resonance, fluorescence microscopy with PIP biosensors, co-immunoprecipitation, and CRISPR knockout screens.
Is phosphatidylinositol phosphate binding involved in disease?
Yes, dysregulated PIP binding is implicated in cancer, neurodegeneration, inflammatory disorders, and iron transport diseases.
What is the difference between PI3P and PI4P binding?
PI3P is enriched on endosomes and autophagosomes and recruits FYVE/PX proteins, while PI4P is enriched on the Golgi and regulates inflammasome and STING signaling.
Can CRISPR be used to study PIP-binding proteins?
Yes, CRISPR knockout, point mutation knock-in, tagged knock-in, and overexpression models are widely used to dissect PIP-binding protein function.
What services does EDITGENE offer for PIP-binding research?
EDITGENE provides knockout cell models, point mutation knock-in, tagged knock-in, overexpression, CRISPR library screening, and bioinformatics support for PIP-binding protein studies.
Conclusion
Phosphatidylinositol phosphate binding (GO:1901981) is a fundamental molecular function that enables cells to decode lipid signals and organize membrane trafficking, signaling, and immune responses. From autophagy regulation by SNX4 to inflammasome activation by PI4P-bound NLRP3, PIP-binding proteins are central to health and disease. Understanding their mechanisms requires precise genetic tools, and CRISPR-based models offer unparalleled specificity for functional dissection. As research uncovers new PIP-binding proteins and their roles in cancer, neurodegeneration, and inflammation, targeting these interactions may yield novel therapeutic strategies.
References
- 1. Askari F et al.. 2023. Phosphatidylinositol 3-phosphate regulates iron transport via PI3P-binding CgPil1 protein.. Cell Rep 42(8):112855 PMID: 37490387
- 2. Chen J et al.. 2018. PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation.. Nature 564(7734):71-76 PMID: 30487600
- 3. Liu X et al.. 2016. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores.. Nature 535(7610):153-8 PMID: 27383986
- 4. Ravussin A et al.. 2021. The phosphatidylinositol 3-phosphate-binding protein SNX4 controls ATG9A recycling and autophagy.. J Cell Sci 134(3) PMID: 33468622
- 5. Amos STA et al.. 2019. Membrane Recognition and Binding by the Phosphatidylinositol Phosphate Kinase PIP5K1A: A Multiscale Simulation Study.. Structure 27(8):1336-1346.e2 PMID: 31204251
- 6. Baksheeva VE et al.. 2020. Membrane Binding of Neuronal Calcium Sensor-1: Highly Specific Interaction with Phosphatidylinositol-3-Phosphate.. Biomolecules 10(2) PMID: 31973069
- 7. Stenmark H et al.. 2002. The phosphatidylinositol 3-phosphate-binding FYVE finger.. FEBS Lett 513(1):77-84 PMID: 11911884
- 8. Han J et al.. 2026. A chemical agonist and the Golgi-resident lipid PI4P activate STING by inducing transmembrane helix rearrangement.. Immunity 59(1):34-47.e9 PMID: 41352342
